Education
About Us
Working with TipRanks
Follow Us
Alphamab Oncology (HK:9966)
:9966
Comparison Results
Ascletis Pharma, Inc.
HK$14.85
HK$14.40B
―
1651.90%
1 Buy
1 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.44
HK$10.41B
428.97
972.41%
1 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$10.18
HK$18.92B
―
313.82%
0 Buy
0 Hold
0 Sell
Hold
Abbisko Cayman Limited
HK$16.82
HK$11.44B
60.09
462.54%
1 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:9966
Alphamab Oncology
10.80
8.27
326.88%
HK:1672
Ascletis Pharma, Inc.
13.84
13.05
1651.90%
HK:2142
HBM Holdings Ltd.
12.44
11.27
963.25%
HK:2157
Lepu Biopharma Co. Ltd. Class H
10.18
7.77
322.41%
HK:2256
Abbisko Cayman Limited
16.82
13.80
456.95%
HK:3681
SinoMab Bioscience Ltd.
2.78
1.51
118.90%